These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 28978036)
1. LncRNA ANCR down-regulation promotes TGF-β-induced EMT and metastasis in breast cancer. Li Z; Dong M; Fan D; Hou P; Li H; Liu L; Lin C; Liu J; Su L; Wu L; Li X; Huang B; Lu J; Zhang Y Oncotarget; 2017 Sep; 8(40):67329-67343. PubMed ID: 28978036 [TBL] [Abstract][Full Text] [Related]
2. The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer. Li Z; Hou P; Fan D; Dong M; Ma M; Li H; Yao R; Li Y; Wang G; Geng P; Mihretab A; Liu D; Zhang Y; Huang B; Lu J Cell Death Differ; 2017 Jan; 24(1):59-71. PubMed ID: 27716745 [TBL] [Abstract][Full Text] [Related]
3. lncRA ANCR Inhibits Non-Small Cell Lung Cancer Cell Migration and Invasion by Inactivating TGF-β Pathway. Wang S; Lan F; Xia Y Med Sci Monit; 2018 Aug; 24():6002-6009. PubMed ID: 30154397 [TBL] [Abstract][Full Text] [Related]
4. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760 [TBL] [Abstract][Full Text] [Related]
5. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance. Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912 [TBL] [Abstract][Full Text] [Related]
6. MiR-23a promotes TGF-β1-induced EMT and tumor metastasis in breast cancer cells by directly targeting CDH1 and activating Wnt/β-catenin signaling. Ma F; Li W; Liu C; Li W; Yu H; Lei B; Ren Y; Li Z; Pang D; Qian C Oncotarget; 2017 Sep; 8(41):69538-69550. PubMed ID: 29050223 [TBL] [Abstract][Full Text] [Related]
7. Downregulated LncRNA-ANCR promotes osteoblast differentiation by targeting EZH2 and regulating Runx2 expression. Zhu L; Xu PC Biochem Biophys Res Commun; 2013 Mar; 432(4):612-7. PubMed ID: 23438432 [TBL] [Abstract][Full Text] [Related]
8. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
9. LncRNA ANCR is positively correlated with transforming growth factor-β1 in patients with osteoarthritis. Li Q; Zhang Z; Guo S; Tang G; Lu W; Qi X J Cell Biochem; 2019 Sep; 120(9):14226-14232. PubMed ID: 31074173 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA ANCR promotes progression of NSCLC by inhibiting E-Ca expression. Zhou T; Fang JJ; Zhou YX; Li ZP; Jiang L; Han WW; Zhu ZH Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1250-1257. PubMed ID: 32096155 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition. Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177 [TBL] [Abstract][Full Text] [Related]
12. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer. Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552 [TBL] [Abstract][Full Text] [Related]
13. The natural compound codonolactone attenuates TGF-β1-mediated epithelial-to-mesenchymal transition and motility of breast cancer cells. Fu J; Ke X; Tan S; Liu T; Wang S; Ma J; Lu H Oncol Rep; 2016 Jan; 35(1):117-26. PubMed ID: 26549400 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA LINC01186, regulated by TGF-β/SMAD3, inhibits migration and invasion through Epithelial-Mesenchymal-Transition in lung cancer. Hao Y; Yang X; Zhang D; Luo J; Chen R Gene; 2017 Apr; 608():1-12. PubMed ID: 28119085 [TBL] [Abstract][Full Text] [Related]
15. TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes. Räsänen K; Vaheri A J Dermatol Sci; 2010 May; 58(2):97-104. PubMed ID: 20399617 [TBL] [Abstract][Full Text] [Related]
16. LncRNA-ANCR regulates the cell growth of osteosarcoma by interacting with EZH2 and affecting the expression of p21 and p27. Zhang F; Peng H J Orthop Surg Res; 2017 Jul; 12(1):103. PubMed ID: 28679390 [TBL] [Abstract][Full Text] [Related]
17. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway. Da C; Liu Y; Zhan Y; Liu K; Wang R Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176 [TBL] [Abstract][Full Text] [Related]
18. Involvement of gelsolin in TGF-beta 1 induced epithelial to mesenchymal transition in breast cancer cells. Chen ZY; Wang PW; Shieh DB; Chiu KY; Liou YM J Biomed Sci; 2015 Oct; 22():90. PubMed ID: 26482896 [TBL] [Abstract][Full Text] [Related]
19. SALL4 activates TGF-β/SMAD signaling pathway to induce EMT and promote gastric cancer metastasis. Zhang X; Zhang P; Shao M; Zang X; Zhang J; Mao F; Qian H; Xu W Cancer Manag Res; 2018; 10():4459-4470. PubMed ID: 30349378 [TBL] [Abstract][Full Text] [Related]
20. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway. Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]